Fundz

Solesis Acquires Polyzen, Expanding Film And Coating Capabilities

PRIVATENov 02, 2022

Acquiring Company

Solesis

Acquired Company

Polyzen

TelfordManufacturingBiotechnologyHealth CareMedical DeviceManufacturingBiotechnologyMedical Device

Description

Polyzen, LLC, announced today that it has been acquired by Solesis, an advanced biomaterials company that develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, and life sciences industries. Solesis is headquartered in Telford, PA, with manufacturing facilities in Pennsylvania and North Carolina.

Quick answer

Solesis is acquiring Polyzen, announced November 2, 2022. Solesis is based in Telford, Pennsylvania, United States.

How much did Solesis pay for Polyzen?
The deal value was not disclosed.
What does Solesis do?
Solesis is an innovative provider of biomaterials solutions and services primarily focused on the MedTech and Biopharma industries.
Where are Solesis and Polyzen based?
Solesis is based in Telford, Pennsylvania, United States.
Who are the decision-makers at Solesis?
Fundz holds 1 contact at Solesis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical Device and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Solesis, and when

When Solesis changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Solesis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Solesis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Solesis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Solesis

Location

Telford, Pennsylvania, United States

About

Solesis is an innovative provider of biomaterials solutions and services primarily focused on the MedTech and Biopharma industries. Through integrated research, development, and manufacturing capabilities, the Solesis family of companies—Charter Medical, Polyzen, SanaVita Medical, and Secant Group—enable technologies and therapies for next-generation patient care. Based in the United States, Solesis employs more than 450 people across five production facilities located in PA and NC.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Solesis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

John
Likely contact at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Solesis's next move

Learn about Strategic plan

Frequently asked

Who acquired Polyzen?

Polyzen was acquired by Solesis, based in Telford. The deal was reported on November 2, 2022. Solesis is an innovative provider of biomaterials solutions and services primarily focused on the MedTech and Biopharma industries. Solesis is privately held and operates in Manufacturing.

When did Solesis acquire Polyzen?

Solesis's acquisition of Polyzen was reported on November 2, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Polyzen do?

Polyzen, LLC, is a leading contract developer and manufacturer of custom medical-grade polymer components and products for the medical device and specialty industrial markets worldwide. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.